Takeuchi, T., Harigai, M., Tanaka, Y., Yamanaka, H., Ishiguro, N., Yamamoto, K., . . . Baker, D. (2013). Golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior treatment with disease-modifying antirheumatic drugs: Results of the phase 2/3, multicentre, randomised, double-blind, placebo-controlled GO-MONO study through 24 weeks. BMJ Publishing Group.
Chicago-стиль цитированияTakeuchi, Tsutomu, et al. Golimumab Monotherapy in Japanese Patients With Active Rheumatoid Arthritis Despite Prior Treatment With Disease-modifying Antirheumatic Drugs: Results of the Phase 2/3, Multicentre, Randomised, Double-blind, Placebo-controlled GO-MONO Study Through 24 weeks. BMJ Publishing Group, 2013.
MLA-цитированиеTakeuchi, Tsutomu, et al. Golimumab Monotherapy in Japanese Patients With Active Rheumatoid Arthritis Despite Prior Treatment With Disease-modifying Antirheumatic Drugs: Results of the Phase 2/3, Multicentre, Randomised, Double-blind, Placebo-controlled GO-MONO Study Through 24 weeks. BMJ Publishing Group, 2013.